Market Research Report
Life Science Tools and Reagents: Global Markets
|Published by||BCC Research||Product code||180726|
|Published||Content info||277 Pages
Delivery time: 1-2 business days
|Life Science Tools and Reagents: Global Markets|
|Published: May 16, 2016||Content info: 277 Pages||
The global market for life sciences tools and reagents reached $45.9 billion in 2014 and $48.2 billion in 2015. The market should reach $58.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 3.8% from 2015 to 2020.
The scope of this study involves the tools and reagents employed in the life sciences markets. The life sciences markets include both the biotechnology and pharmaceutical industries. The tools and reagents covered in this report are used to conduct research in the domains of genomics (DNA and RNA research), proteomics, cell biology research, epigenetics, metabolomics, bioinformatics, imaging and microscopy and stem cell research. Also included are the markets of recombinant proteins, antibodies and animal models.
Excluded from this report are immunoassays employed in life science research. Immunoassays include enzyme immunoassays, fluorescent immunoassays, chemiluminescence immunoassays, radioimmunoassays and others. They have applications in diagnostics, neonatal screening, protein detection, etc. In addition, filtration devices (cross-flow filtration, membrane filters, micron filters, etc.), blotting membranes and bioreactors used for the production of recombinant proteins and enzymes in bacterial and mammalian cell cultures will not be considered in this report.
This study surveys each market in all the geographic regions including North America, Europe and Emerging countries. The Emerging market covers the countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.
BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The latest developments including new products, mergers and acquisitions in each market are also dealt with in detail. Also included in the report are relevant patent analysis and comprehensive profiles of companies that are dominant in the life science tools and reagents industry. The key market players are Thermo Fisher Scientific Inc., Merck KGaA (includes EMD Millipore and Sigma-Aldrich), Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Danaher Corp., Bio-Techne Corp., Waters Corp., Bruker Corp., Perkin Elmer Inc., Qiagen N.V., Becton, Dickinson and Company (includes BD Life Sciences), Illumina Inc., Roche, Promega Corp. and many others.
The study has been carried out by a team of professionals in the biotechnology industry. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 14 years of industry experience. She was awarded a Gold Medal by the Prime Minister of India for her work in the pharmaceutical and biotechnology industries and has worked with top companies in India and in the U.S.